EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant Treatment of Advanced Penile Cancer

NCT07518979 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Penile Cancer

Interventions

DRUG: Becotatug Vedotin
DRUG: Pucotenlimab

Sponsor

Jiyan Liu

Collaborators

[object Object]
[object Object]